More Marketing Wars: Lantus vs. Levemir

Another larger-than-life Diabetes Marketing War, this time without the romantic names:A while back I wrote a post introducing the first-ever competitor to Sanofi-Aventis' long-acting insulin, Lantus. The new product is called Levemir, from Novo N...

Source: Diabetes Mine - July 5, 2006 Category: Endocrinology Authors: Amy Tenderich Source Type: blogs